Ri Cui

4.2k total citations
76 papers, 2.9k citations indexed

About

Ri Cui is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ri Cui has authored 76 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 32 papers in Cancer Research and 17 papers in Oncology. Recurrent topics in Ri Cui's work include MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (18 papers) and RNA modifications and cancer (15 papers). Ri Cui is often cited by papers focused on MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (18 papers) and RNA modifications and cancer (15 papers). Ri Cui collaborates with scholars based in China, United States and Japan. Ri Cui's co-authors include Carlo M. Croce, Tae‐Wan Kim, Guang Liang, Kazuhisa Takahashi, Young-Jun Jeon, Fumiyuki Takahashi, Koichi Matsuda, Xiangjie Huang, Zhenghua Luo and Esmerina Tili and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Ri Cui

71 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ri Cui China 32 2.0k 1.3k 467 324 270 76 2.9k
Yujuan Dong China 32 2.9k 1.4× 1.9k 1.4× 670 1.4× 327 1.0× 231 0.9× 48 3.7k
Jiong Bi China 27 1.7k 0.9× 1.0k 0.8× 594 1.3× 265 0.8× 169 0.6× 51 2.5k
Qian Zhao China 31 2.4k 1.2× 1.6k 1.2× 450 1.0× 233 0.7× 198 0.7× 110 3.4k
Caiping Ren China 31 1.7k 0.9× 896 0.7× 543 1.2× 296 0.9× 187 0.7× 116 2.6k
Kasper Thorsen Denmark 28 1.8k 0.9× 826 0.6× 312 0.7× 257 0.8× 190 0.7× 43 2.7k
Pedro P. Medina Spain 26 2.8k 1.4× 1.6k 1.2× 453 1.0× 289 0.9× 462 1.7× 60 3.4k
Jianxin Jiang China 34 1.8k 0.9× 1.3k 0.9× 586 1.3× 197 0.6× 156 0.6× 99 2.6k
Qinong Ye China 31 2.1k 1.1× 1.2k 0.9× 536 1.1× 248 0.8× 153 0.6× 117 2.9k
Germana Castelli Italy 29 1.6k 0.8× 950 0.7× 798 1.7× 478 1.5× 232 0.9× 97 3.1k

Countries citing papers authored by Ri Cui

Since Specialization
Citations

This map shows the geographic impact of Ri Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ri Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ri Cui more than expected).

Fields of papers citing papers by Ri Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ri Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ri Cui. The network helps show where Ri Cui may publish in the future.

Co-authorship network of co-authors of Ri Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Ri Cui. A scholar is included among the top collaborators of Ri Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ri Cui. Ri Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Qi, Tao Zhang, Jieyu Liu, et al.. (2025). Polydatin enhances oxaliplatin-induced cell death by activating NOX5-ROS-mediated DNA damage and ER stress in colon cancer cells. Frontiers in Pharmacology. 15. 1532695–1532695. 1 indexed citations
2.
3.
Lü, Hui, Yiqun Xia, Ying Yan, et al.. (2025). Panobinostat potentiates adagrasib-induced cell death by triggering autophagy in human non-small cell lung cancer. Cell Death Discovery. 11(1). 360–360.
4.
Shangguan, Fugen, et al.. (2025). Demethoxycurcumin induces metabolic crisis and ATF4/ATF3/CHOP-dependent cell death in hepatocellular carcinoma. Chemico-Biological Interactions. 418. 111584–111584.
5.
Lin, Haizhen, et al.. (2025). Dihydrotanshinone I potentiates the anti-tumor activity of cisplatin by activating ROS-mediated ER stress through targeting HSPD1 in lung cancer cells. European Journal of Pharmacology. 994. 177378–177378. 4 indexed citations
6.
Wu, Tao, et al.. (2024). Tubeimoside-I, an inhibitor of HSPD1, enhances cytotoxicity of oxaliplatin by activating ER stress and MAPK signaling pathways in colorectal cancer. Journal of Ethnopharmacology. 336. 118754–118754. 6 indexed citations
7.
8.
9.
Qiu, Chenyu, Xin Shen, Hui Lü, et al.. (2023). Combination therapy with HSP90 inhibitors and piperlongumine promotes ROS-mediated ER stress in colon cancer cells. Cell Death Discovery. 9(1). 375–375. 10 indexed citations
10.
Srivastava, Amit Kumar, Ananya Banerjee, Tiantian Cui, et al.. (2019). Inhibition of miR-328–3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer. Cancer Research. 79(9). 2314–2326. 74 indexed citations
11.
Zhang, Qianqian, Weiqian Chen, Xiuling Lv, et al.. (2019). Piperlongumine, a Novel TrxR1 Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cells by ROS-Mediated ER Stress. Frontiers in Pharmacology. 10. 1180–1180. 42 indexed citations
12.
Yin, Changtian, Xuanxuan Dai, Xiangjie Huang, et al.. (2019). Alantolactone promotes ER stress‐mediated apoptosis by inhibition of TrxR1 in triple‐negative breast cancer cell lines and in a mouse model. Journal of Cellular and Molecular Medicine. 23(3). 2194–2206. 32 indexed citations
13.
Wei, Huijun, Ri Cui, Nicola Zanesi, et al.. (2017). miR-130a Deregulates PTEN and Stimulates Tumor Growth. Cancer Research. 77(22). 6168–6178. 53 indexed citations
14.
Suh, Sung-Suk, Ji Young Yoo, Ri Cui, et al.. (2014). FHIT Suppresses Epithelial-Mesenchymal Transition (EMT) and Metastasis in Lung Cancer through Modulation of MicroRNAs. PLoS Genetics. 10(10). e1004652–e1004652. 59 indexed citations
15.
Meng, Wei, Zhenqing Ye, Ri Cui, et al.. (2013). MicroRNA-31 Predicts the Presence of Lymph Node Metastases and Survival in Patients with Lung Adenocarcinoma. Clinical Cancer Research. 19(19). 5423–5433. 93 indexed citations
16.
Kumar, Vinod, Keitaro Matsuo, Atsushi Takahashi, et al.. (2011). Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility. Journal of Human Genetics. 56(6). 436–439. 16 indexed citations
17.
Ohashi, Rina, Ken Tajima, Ri Cui, et al.. (2009). Osteopontin Modulates Malignant Pleural Mesothelioma Cell Functions in Vitro. Haigan. 49(4). 368–375. 13 indexed citations
18.
Ohashi, Rina, Fumiyuki Takahashi, Ri Cui, et al.. (2007). Interaction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cell. Cancer Letters. 252(2). 225–234. 76 indexed citations
19.
Cui, Ri, Rina Ohashi, Fumiyuki Takahashi, et al.. (2007). Signal transduction mediated by endostatin directly modulates cellular function of lung cancer cells in vitro. Cancer Science. 98(6). 830–837. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yujuan Dong Breakdown of academic impact, for papers by Jiong Bi Breakdown of academic impact, for papers by Qian Zhao Breakdown of academic impact, for papers by Caiping Ren Breakdown of academic impact, for papers by Kasper Thorsen Breakdown of academic impact, for papers by Pedro P. Medina Breakdown of academic impact, for papers by Jianxin Jiang Breakdown of academic impact, for papers by Qinong Ye Breakdown of academic impact, for papers by Germana Castelli
Rankless by CCL
2026